AJANTPHARM.BO | Ajanta Pharma Limited Annual & Quarterly

Annual Balance Sheets

(In INR)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	46.38 Billion	46.79 Billion	40.55 Billion	37.78 Billion	33.18 Billion	26.96 Billion
Total Current Assets	27.3 Billion	28.34 Billion	22.64 Billion	20.27 Billion	16.41 Billion	11.81 Billion
Cash And Short Term Investments	4.6 Billion	8.43 Billion	3.28 Billion	3.78 Billion	2.69 Billion	1.59 Billion
Cash and Cash Equivalents	1.3 Billion	3.29 Billion	2.06 Billion	1.77 Billion	2.02 Billion	951.6 Million
Short Term Investments	3.3 Billion	5.13 Billion	1.21 Billion	2 Billion	671.4 Million	647.4 Million
Net Receivables	12.8 Billion	10.83 Billion	11.45 Billion	7.59 Billion	8.31 Billion	5.5 Billion
Inventory	8.28 Billion	8.15 Billion	7.91 Billion	7.66 Billion	4.95 Billion	4.35 Billion
Other Current Assets	1.6 Billion	916.1 Million	200 Thousand	1.23 Billion	8.76 Billion	5.85 Billion
Total Non-Current Assets	19.07 Billion	18.45 Billion	17.91 Billion	17.51 Billion	16.76 Billion	15.14 Billion
Net PPE	17.2 Billion	16.98 Billion	16.47 Billion	16.29 Billion	15.82 Billion	14.33 Billion
Good Will And Intangible Assets	146.6 Million	77.5 Million	90.2 Million	107.9 Million	117.1 Million	66.5 Million
Good Will	-	-	-	-	-	-
Intangible Assets	146.6 Million	77.5 Million	90.2 Million	107.9 Million	117.1 Million	66.5 Million
Long-Term Investments	279.4 Million	290 Million	294.2 Million	39.5 Million	159.3 Million	130 Million
Tax Assets	1.34 Billion	967.7 Million	555.5 Million	501 Million	254 Million	318.1 Million
Other Non Current Assets	94.4 Million	133.4 Million	497.1 Million	566.8 Million	410.4 Million	303.1 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	10.71 Billion	12.91 Billion	7.91 Billion	7.83 Billion	7.19 Billion	4.5 Billion
Total Current Liabilities	8.95 Billion	11.39 Billion	6.47 Billion	6.48 Billion	6.06 Billion	3.77 Billion
Account Payables	4.63 Billion	4.22 Billion	3.27 Billion	3.73 Billion	3.62 Billion	2.25 Billion
Tax Payables	447.7 Million	330.7 Million	79.4 Million	489.2 Million	117 Million	-
Short Term Debt	117.6 Million	94.3 Million	64.6 Million	115.9 Million	622.5 Million	353 Million
Deferred Revenue	447.7 Million	6.83 Billion	2.49 Billion	2.32 Billion	1.81 Billion	-353 Million
Other Current Liabilities	3.76 Billion	231.5 Million	644.1 Million	304.2 Million	3.3 Million	1.52 Billion
Total Non Current Liabilities	1.75 Billion	1.51 Billion	1.43 Billion	1.34 Billion	1.13 Billion	733.3 Million
Long-Term Debt	235.2 Million	262 Million	185.7 Million	197.7 Million	127.1 Million	6.6 Million
Deferred Revenue Non Current	-1.00	26.7 Million	30 Million	33.4 Million	36.7 Million	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	432.5 Million	251.6 Million	204.1 Million	191.8 Million	161.1 Million	137.7 Million
Other Liabilities	1.00	-	-	-	-	-
Total Equity	35.67 Billion	33.87 Billion	32.64 Billion	29.95 Billion	25.98 Billion	22.45 Billion
Stock Holders Equity	35.67 Billion	33.87 Billion	32.64 Billion	29.95 Billion	25.98 Billion	22.45 Billion
Common Stock	252.7 Million	252.7 Million	171.7 Million	173.9 Million	175.4 Million	175.4 Million
Retained Earnings	33.14 Billion	31.41 Billion	27.17 Billion	21.55 Billion	16.17 Billion	12.69 Billion
Accumulated other comprehensive income	35.42 Billion	2.21 Billion	5.29 Billion	8.22 Billion	-4.88 Billion	-4.05 Billion
Common Stock Equity	35.67 Billion	33.87 Billion	32.64 Billion	29.95 Billion	25.98 Billion	22.45 Billion
Capital Lease Obligation	235.2 Million	342 Million	231.2 Million	296.7 Million	292.8 Million	26.2 Million
Total Investments	3.57 Billion	361.9 Million	294.2 Million	39.5 Million	159.3 Million	130 Million
Total Debt	352.8 Million	356.3 Million	250.3 Million	313.6 Million	749.6 Million	359.6 Million
Net Debt	-954.9 Million	-2.94 Billion	-1.81 Billion	-1.46 Billion	-1.27 Billion	-592 Million

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	47.9 Billion	-	46.38 Billion	46.38 Billion	-	44.33 Billion
Total Current Assets	27.94 Billion	4.59 Billion	27.3 Billion	27.3 Billion	4.75 Billion	25.62 Billion
Cash And Short Term Investments	7.57 Billion	4.59 Billion	4.6 Billion	4.6 Billion	4.75 Billion	4.81 Billion
Cash and Cash Equivalents	638.9 Million	-4.59 Billion	1.3 Billion	1.3 Billion	-4.75 Billion	2.61 Billion
Short Term Investments	6.93 Billion	9.19 Billion	3.3 Billion	3.3 Billion	9.51 Billion	2.19 Billion
Net Receivables	10.36 Billion	-	12.8 Billion	12.8 Billion	-	11.63 Billion
Inventory	8.45 Billion	-	8.28 Billion	8.28 Billion	-	7.85 Billion
Other Current Assets	11.91 Billion	-	1.6 Billion	1.6 Billion	-	1.31 Billion
Total Non-Current Assets	19.95 Billion	-4.59 Billion	19.07 Billion	19.07 Billion	-4.75 Billion	18.7 Billion
Net PPE	17.86 Billion	-	17.2 Billion	17.2 Billion	-	16.8 Billion
Good Will And Intangible Assets	133.2 Million	-	146.6 Million	146.6 Million	-	90.6 Million
Good Will	-	-	-	-	-	-
Intangible Assets	133.2 Million	-	146.6 Million	146.6 Million	-	90.6 Million
Long-Term Investments	340 Million	-	279.4 Million	279.4 Million	-	-1.83 Billion
Tax Assets	1.46 Billion	-	1.34 Billion	1.34 Billion	-	1.33 Billion
Other Non Current Assets	152.3 Million	-4.59 Billion	94.4 Million	94.4 Million	-4.75 Billion	2.31 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	11.13 Billion	-35.67 Billion	10.71 Billion	10.71 Billion	-	9.51 Billion
Total Current Liabilities	9.09 Billion	-	8.95 Billion	8.95 Billion	-	7.99 Billion
Account Payables	4.2 Billion	-	4.63 Billion	4.63 Billion	-	3.61 Billion
Tax Payables	552 Million	-	447.7 Million	447.7 Million	-	815.2 Million
Short Term Debt	24.2 Million	-	117.6 Million	117.6 Million	-	105.5 Million
Deferred Revenue	552 Million	-	447.7 Million	447.7 Million	-	4.02 Billion
Other Current Liabilities	4.3 Billion	-	3.76 Billion	3.76 Billion	-	251.5 Million
Total Non Current Liabilities	2.04 Billion	-35.67 Billion	1.75 Billion	1.75 Billion	-	1.52 Billion
Long-Term Debt	-	-	235.2 Million	235.2 Million	-	224.7 Million
Deferred Revenue Non Current	-	-	-1.00	-1.00	-	242.4 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	919.8 Million	-35.67 Billion	432.5 Million	432.5 Million	-	25 Million
Other Liabilities	-	-	1.00	1.00	-	-
Total Equity	36.76 Billion	35.67 Billion	35.67 Billion	35.67 Billion	34.81 Billion	34.81 Billion
Stock Holders Equity	36.76 Billion	35.67 Billion	35.67 Billion	35.67 Billion	34.81 Billion	34.81 Billion
Common Stock	250.7 Million	-	252.7 Million	252.7 Million	-	252.7 Million
Retained Earnings	-	-	33.14 Billion	33.14 Billion	-	-
Accumulated other comprehensive income	-	35.67 Billion	35.42 Billion	35.42 Billion	34.81 Billion	34.56 Billion
Common Stock Equity	36.76 Billion	35.67 Billion	35.67 Billion	35.67 Billion	34.81 Billion	34.81 Billion
Capital Lease Obligation	303.7 Million	-	235.2 Million	235.2 Million	-	321.1 Million
Total Investments	340 Million	9.19 Billion	3.57 Billion	3.57 Billion	9.51 Billion	360.5 Million
Total Debt	24.2 Million	-	352.8 Million	352.8 Million	-	330.2 Million
Net Debt	-614.7 Million	4.59 Billion	-954.9 Million	-954.9 Million	4.75 Billion	-2.28 Billion

Balance Sheet Charts

TOBA, INC.

7472

Full Analysis

Annual Balance Sheets
Insight Enterprises, Inc.

NSIT

Full Analysis

Annual Balance Sheets
Eagle Football Group Société anonyme

EFG

Full Analysis

Annual Balance Sheets
Phoenix Silicon International Corporation

8028

Full Analysis

Annual Balance Sheets
NantHealth, Inc.

NHIQ

Full Analysis

Annual Balance Sheets
Kurita Water Industries Ltd.

KTWIF

Full Analysis

Annual Balance Sheets

Global Stocks Search

Ajanta Pharma Limited (AJANTPHARM.BO)

Annual Balance Sheets

Balance Sheet Charts

TOBA, INC.

Insight Enterprises, Inc.

Eagle Football Group Société anonyme

Phoenix Silicon International Corporation

NantHealth, Inc.

Kurita Water Industries Ltd.